Sale!

CCDC103 Gene Primary Ciliary Dyskinesia Type 17 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CCDC103 Gene Primary Ciliary Dyskinesia Type 17 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the CCDC103 gene responsible for Primary Ciliary Dyskinesia (PCD) Type 17. This next-generation sequencing test analyzes the complete coding region of the CCDC103 gene to detect pathogenic variants that disrupt ciliary function, leading to chronic respiratory infections, sinusitis, and fertility issues. The test provides crucial information for patients experiencing recurrent respiratory symptoms, chronic cough, nasal congestion, and bronchiectasis. At only $500 USD, this advanced genetic analysis helps guide personalized treatment strategies and provides definitive diagnosis for individuals with suspected ciliary dysfunction disorders. Early detection through this test enables proactive management and improved quality of life for affected individuals.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CCDC103 Gene Primary Ciliary Dyskinesia Type 17 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Respiratory Health

The CCDC103 Gene Primary Ciliary Dyskinesia Type 17 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for individuals suffering from chronic respiratory conditions and suspected ciliary dysfunction disorders. This advanced genetic test utilizes cutting-edge Next-Generation Sequencing (NGS) technology to provide definitive answers about the genetic basis of Primary Ciliary Dyskinesia Type 17, enabling precise diagnosis and personalized treatment approaches.

What This Test Measures and Detects

This comprehensive genetic analysis specifically targets the CCDC103 gene, which plays a critical role in the structure and function of motile cilia throughout the body. The test identifies:

  • Pathogenic mutations in the CCDC103 gene coding regions
  • Single nucleotide variants (SNVs) affecting ciliary protein function
  • Insertion and deletion mutations disrupting normal gene expression
  • Copy number variations that may impact ciliary assembly
  • Genetic variants associated with impaired mucociliary clearance

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing:

  • Chronic respiratory infections beginning in infancy or early childhood
  • Persistent nasal congestion and sinusitis unresponsive to conventional treatments
  • Recurrent middle ear infections and hearing loss
  • Chronic productive cough with bronchiectasis development
  • Neonatal respiratory distress requiring extended oxygen support
  • Laterality defects such as situs inversus or heterotaxy
  • Male infertility due to impaired sperm motility
  • Family history of Primary Ciliary Dyskinesia or related respiratory disorders

Clinical Benefits of Genetic Testing

Undergoing the CCDC103 gene test provides numerous advantages for patients and healthcare providers:

  • Definitive Diagnosis: Confirms or rules out Primary Ciliary Dyskinesia Type 17 with high accuracy
  • Personalized Treatment: Enables targeted therapies based on specific genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates proactive management to prevent complications
  • Disease Monitoring: Establishes baseline for tracking disease progression
  • Research Contribution: Advances understanding of ciliary disorders through genetic data

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and medical geneticists. Results typically fall into three categories:

  • Positive Result: Identifies pathogenic mutations in the CCDC103 gene, confirming Primary Ciliary Dyskinesia Type 17 diagnosis
  • Negative Result: No disease-causing variants detected, though other genetic or non-genetic causes should be considered
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unclear clinical impact, requiring further evaluation

All positive results include detailed explanations of the specific mutation, its inheritance pattern, and implications for family members. Our genetic counseling team provides comprehensive support to help you understand your results and make informed healthcare decisions.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take Control of Your Respiratory Health Today

Don’t let unexplained respiratory symptoms compromise your quality of life. The CCDC103 Gene Primary Ciliary Dyskinesia Type 17 NGS Genetic DNA Test provides the answers you need for proper diagnosis and effective treatment. Our experienced team is ready to guide you through the testing process and help you understand your genetic health.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take the first step toward definitive diagnosis and personalized care for your respiratory health concerns.